Other studies showed that miR-7 perturbs the invasive potential of human breast cancer cells and sensitizes them to DNA damage via directly targeting SET domain-containing (lysine methyltransferase) 8 (SET8) [103]. This evidence concerns the gene KMT5A and breast carcinoma.